Prescription Drug Prices: Are We Getting Our Money's Worth? : a Majority Staff Report of the Special Committee on Aging, United States Senate |
Other editions - View all
Common terms and phrases
25 largest U.S. APPENDIX award buyer CIMETIDINE Claims Court Committee on Aging Consumer Price Index Court of Claims Ct.Cl damages DAVID PRYOR determined discounts domain theory drug costs Drug Evaluations Statistical drug price increases drug products Drugs by Therapeutic DRUGS INTRODUCED eminent domain entire compensation Etoposide Evaluations Statistical Reports existing drug therapies FAMOTIDINE Farmindustria FDA New Drug federal Food federal government Glaxo H2 Antagonists Hambrecht and Quist infringement July Leesona Medicaid program Medicare Molecular Entities N/A N/A NMES Number owner Pace Alliance Parke-Davis patent holder pharmaceutical manufacturers PIROXICAM plaintiff potential for therapeutic prescription drug manufacturers prescription drug prices Price Index Price Paid Purdue University RANITIDINE Rated Modest reasonable and entire reimbursement Research rising drug royalty Rx Drug Senate Special Committee Suite 2A Lawrence TAGAMET therapeutic gain Therapeutic Potential tort theory United States Claims ZANTAC Тор